Pan-Serotype Diagnostic for Foot-and-Mouth Disease Using the Consensus Antigen of Nonstructural Protein 3B

Alyssa K Van Dreumel1, Wojtek P Michalski2, Leanne M McNabb2

  • 1CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia School of Medicine, Faculty of Health, Deakin University, Geelong, Victoria, Australia.

Insights

A new consensus amino acid sequence for foot-and-mouth disease virus (FMDV) nonstructural protein 3B was developed. This sequence enables a pan-serotype diagnostic test for all seven FMDV serotypes.

Area of Science:

  • Veterinary Virology
  • Immunodiagnostics
  • Molecular Biology

Background:

  • Foot-and-mouth disease virus (FMDV) poses a significant threat to livestock globally.
  • Accurate and broad-spectrum diagnostic tests are crucial for FMDV control.
  • Existing diagnostics may not cover all seven FMDV serotypes effectively.

Purpose of the Study:

  • To develop a consensus amino acid sequence for the FMDV nonstructural protein 3B.
  • To create a pan-serotype diagnostic test capable of detecting antibodies against all seven FMDV serotypes.
  • To evaluate the diagnostic performance of the developed assay.

Main Methods:

  • Multiple-sequence alignment of 125 FMDV 3B protein sequences to determine consensus.
  • Expression and purification of the consensus 3B (c3B) protein as a recombinant fusion protein (MBP-c3B).
  • Development of a competition enzyme-linked immunosorbent assay (cELISA) using MBP-c3B as the antigen.

Main Results:

  • The consensus 3B (c3B) protein was successfully expressed and purified.
  • The cELISA demonstrated high diagnostic performance: 87.22% sensitivity and 93.15% specificity.
  • The MBP-c3B antigen showed reactivity with sera from all seven FMDV serotypes, confirming pan-serotype capability.

Conclusions:

  • The developed consensus antigen (c3B) is a promising bioreagent for FMDV diagnostics.
  • The competition ELISA using c3B shows potential as a pan-serotype diagnostic test for FMDV infection.
  • This approach offers a unified strategy for detecting FMDV across all its serotypes.

Related Concept Videos